Latest Period
Q1 2026
Security Snapshot
Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) Institutional Ownership
CUSIP: 05153U107
13F Institutional Holders and Ownership History from Q4 2021 to Q1 2026
Institutions Reporting
125
Shares (Excl. Options)
50,880,612
Price
$6.69
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Symbol
- AURA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 50,880,612
- Total 13F value
- $340,347,350
- Portfolio coverage rank
- 0%
- Share change
- +536,283
- Value change
- +$4,373,812
- Number of holders
- 125
- Shares outstanding
- 96,296,293
- SEC-reported price per share
- $8.29
- Insider filing price
- $8.29
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share is tracked under CUSIP 05153U107.
- 125 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 116 to 125 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $273,791,080 to $340,347,350.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 125 institutions filings for Q1 2026.
Security key
05153U107
Latest holder period
Q1 2026
13F holders
125
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
AURA full holder history
Aura Biosciences, Inc. SEC filings
Aura Biosciences, Inc. company facts
Aura Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 05153U107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
AURA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TCG Crossover GP II, LLC | 9.9% | $64,540,664 | 9,533,333 | Chen Yu | 05 May 2026 | |||
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.6% | +25% | $30,091,360 | +$10,524,518 | 4,701,775 | +54% | Suvretta Capital Management, LLC | 30 Jun 2025 |
| Frazier Life Sciences Public Fund, L.P. | 6.3% | +26% | $20,523,185 | +$4,675,216 | 4,032,060 | +30% | Frazier Life Sciences Public Fund, L.P. | 31 Dec 2025 |
| BlackRock, Inc. | 5.4% | +10% | $20,617,314 | +$1,842,342 | 3,336,027 | +9.8% | BlackRock, Inc. | 30 Sep 2025 |
| Long Focus Capital Management, LLC | 6.6% | +75% | $18,324,093 | +$4,481,180 | 3,319,582 | +32% | LONG FOCUS CAPITAL MANAGEMENT, LLC | 31 Mar 2025 |
| Advent Life Sciences LLP | 3.3% | $11,768,148 | 2,071,857 | Rajesh Parekh, Ph.D. | 13 Feb 2026 |
As of 31 Mar 2026, 125 institutional investors reported holding 50,880,612 shares of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA). This represents 53% of the company’s total 96,296,293 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
50%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP | 7.2% | 6,922,870 | 0% | 100% | $46,314,000 |
| Frazier Life Sciences Management, L.P. | 5.3% | 5,100,000 | 0% | 0.88% | $34,119,000 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.1% | 4,881,125 | 0% | 0.05% | $32,654,726 |
| Long Focus Capital Management, LLC | 4.8% | 4,619,582 | 0% | 1.4% | $30,905,004 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.5% | 4,372,884 | 0% | 0.79% | $29,254,594 |
| BlackRock, Inc. | 3.7% | 3,586,640 | +0.74% | 0% | $23,994,623 |
| Medicxi Ventures Management (Jersey) Ltd | 3.2% | 3,039,892 | 0% | 2.1% | $20,336,877 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.3% | 2,243,828 | 0% | 0% | $15,011,209 |
| Nantahala Capital Management, LLC | 2.2% | 2,117,697 | 0% | 0.88% | $14,167,393 |
| FRANKLIN RESOURCES INC | 2.2% | 2,072,726 | -5.7% | 0% | $13,866,537 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 1,310,862 | +4.4% | 0% | $8,770,106 |
| MILLENNIUM MANAGEMENT LLC | 1.1% | 1,097,627 | +78% | 0.01% | $7,343,125 |
| STATE STREET CORP | 1% | 964,670 | +4.1% | 0% | $6,453,642 |
| LEVIN CAPITAL STRATEGIES, L.P. | 0.98% | 941,400 | -9.1% | 0.48% | $6,297,966 |
| B Group, Inc. | 0.62% | 597,576 | +4.4% | 3% | $3,997,783 |
| ACORN CAPITAL ADVISORS, LLC | 0.62% | 595,744 | 0% | 1.1% | $3,985,527 |
| DIMENSIONAL FUND ADVISORS LP | 0.58% | 558,158 | +7.8% | 0% | $3,731,852 |
| Balyasny Asset Management L.P. | 0.58% | 557,654 | 0.01% | $3,730,705 | |
| Regency Capital Management Inc.\DE | 0.55% | 532,495 | -1.1% | 1.6% | $3,562,392 |
| NORTHERN TRUST CORP | 0.45% | 430,522 | +4.3% | 0% | $2,880,191 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.43% | 415,191 | -6.2% | 0% | $2,779,000 |
| VANGUARD FIDUCIARY TRUST CO | 0.41% | 397,160 | 0% | 0% | $2,657,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.41% | 391,334 | 0% | 0% | $2,618,024 |
| Caligan Partners LP | 0.24% | 229,864 | 0.11% | $1,537,790 | |
| MORGAN STANLEY | 0.23% | 224,041 | +2.6% | 0% | $1,498,834 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
18
Latest
Q1 2026
Rows shown
1-18 of 18
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 50,880,612 | $340,347,350 | +$4,373,812 | $6.69 | 125 |
| 2025 Q4 | 50,234,935 | $273,791,080 | -$8,935,762 | $5.45 | 116 |
| 2025 Q3 | 51,649,516 | $319,192,259 | +$6,254,107 | $6.18 | 106 |
| 2025 Q2 | 50,616,053 | $316,863,119 | +$67,408,487 | $6.26 | 102 |
| 2025 Q1 | 39,264,901 | $230,096,030 | -$11,860,142 | $5.86 | 91 |
| 2024 Q4 | 39,449,434 | $324,276,778 | +$16,157,250 | $8.22 | 93 |
| 2024 Q3 | 36,866,668 | $329,191,609 | -$25,783,402 | $8.91 | 81 |
| 2024 Q2 | 39,765,227 | $300,437,451 | +$3,314,060 | $7.56 | 75 |
| 2024 Q1 | 39,115,323 | $307,072,789 | +$16,222,241 | $7.85 | 77 |
| 2023 Q4 | 36,998,812 | $327,811,496 | +$89,731,106 | $8.86 | 71 |
| 2023 Q3 | 26,323,010 | $236,119,190 | -$5,574,466 | $8.97 | 62 |
| 2023 Q2 | 27,066,492 | $334,426,517 | +$24,980,886 | $12.35 | 59 |
| 2023 Q1 | 25,069,599 | $232,645,346 | +$10,922,124 | $9.28 | 57 |
| 2022 Q4 | 23,806,818 | $250,037,016 | +$78,469,205 | $10.50 | 49 |
| 2022 Q3 | 16,317,002 | $295,663,462 | +$9,714,465 | $18.12 | 43 |
| 2022 Q2 | 15,793,428 | $223,796,376 | +$29,644,466 | $14.17 | 42 |
| 2022 Q1 | 13,702,730 | $298,756,000 | +$9,092,301 | $22.00 | 34 |
| 2021 Q4 | 13,081,587 | $220,131,000 | +$220,131,000 | $16.98 | 32 |